SCIENTIFIC EVIDENCE

Allogeneic Expanded Human Peripheral NK Cells Control Prostate Cancer Growth in a Preclinical Mouse Model of Castration-Resistant Prostate Cancer.

Journal of immunology research
Wang F, Dong X, Wang J, Yang F, Liu D, Ma J, Liu S, Chang D, Xing N.

Publication Overview

Key findings, Countstar context, and access to the original paper.
2022
Cancer Research
Immunology
No items found.
Key Finding
Therefore, the study suggested that the expanded NK cells exhibited significant cytotoxicity against PCa cell lines in vitro and excellent therapeutic efficacy against CRPC in a xenograft mouse model, which was of great value for the clinical treatment of CRPC.
Countstar Connection
Countstar (model not specified) supported assessment of cell number and viability in NK-cell samples during growth assessment in the 2022 Journal of immunology research study.
View paper ↗
Stay Connected toCountstar Science
Get new publications, application notes, cell analysis insights, and Countstar updates delivered to your inbox.
Meet us online
Products
About Us
Contact
© 2026 Countstar. All rights reserved.